机译:遗传变异的BCL11A的类胡萝卜素增强剂确定胎儿血红蛋白水平
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA,Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA,Harvard Medical School, Boston, MA 02115, USA;
Harvard Medical School, Boston, MA 02115, USA,Howard Hughes Medical Institute, Boston, MA 02115, USA;
Montreal Heart Institute and Universite Montreal, Montreal, Quebec H1T 1C8, Canada;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA,Harvard Medical School, Boston, MA 02115, USA;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA;
Harvard Medical School, Boston, MA 02115, USA;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA;
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA;
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA,Department of Medicine, University of Washington, Seattle, WA 98195, USA;
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA,Department of Medicine, University of Washington, Seattle, WA 98195, USA;
Department of Pediatrics, Stanford University, Palo Alto, CA 94304, USA;
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA ,Harvard SchooL. of Public Health, Boston, MA 02115, USA;
Department of Pediatrics, Stanford University, Palo Alto, CA 94304, USA;
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA,Department of Medicine, University of Washington, Seattle, WA 98195, USA;
Montreal Heart Institute and Universite Montreal, Montreal, Quebec H1T 1C8, Canada;
Division of Hematotogy/Oncology, Boston Children's Hospital, Boston, MA 02115, USA,Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA,Harvard Medical School, Boston, MA 02115, USA,Howard Hughes Medical Institute, Boston, MA 02115, USA;
机译:BCL11A红细胞增强剂的破坏重新激活β-地中海贫血症患者红霉细胞中的胎儿血红蛋白
机译:用于镰状细胞疾病的前体内基因编辑细胞疗法:BCL11A红细胞增强子的破坏含有锌指核酸酶增加了甲虫的胎儿血红蛋白动员的人CD34 +细胞
机译:印度镰状细胞病患者中BCL11A(rs1427407)的遗传变异与HBS1-MYB(rs6934903)基因座的变异与胎儿血红蛋白水平无关
机译:与雌激素水平,性激素结合球蛋白和胎儿生长受限相关的胎儿遗传多态性
机译:胎儿血红蛋白和F细胞变异的药物遗传学。
机译:遗传变异导致的BCL11A红系增强剂决定胎儿血红蛋白水平
机译:在喀麦隆镰状细胞病患者中,BCL11A类红细胞特异性增强子的变异与胎儿血红蛋白水平之间的关联:对未来治疗干预的意义